| 000 | 00000nam##2200000za#4500 |
| 001 | 9.573627 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624183805 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406|1999||||xxc|||||o f|0| 0 eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-2/67-14-1999E-PDF |
|---|
| 110 | 1 |aCanada.|bHealth Canada. |bTherapeutic Products Directorate. |
|---|
| 245 | 10|aTesting for carcinogenicity of pharmaceuticals / |h[electronic resource]|c[issued by the] Therapeutic Products Programme. |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |c1999, c2000. |
|---|
| 300 | |a16p.|breferences |
|---|
| 490 | 1 |aGuidance for industry|vICH Topic S1B |
|---|
| 500 | |aThe catalogue number (H42–2-67-14-1999E) and ISBN (0-662-28445-3) for the print edition have been incorrectly copied in this electronic publication. |
|---|
| 590 | |a12-14-Supp|b2012-04-10 |
|---|
| 690 | 07|aCancer|2gcpds |
|---|
| 690 | 07|aDrugs|2gcpds |
|---|
| 690 | 07|aPharmaceutical industry|2gcpds |
|---|
| 690 | 07|aTesting|2gcpds |
|---|
| 775 | 08|tÉvaluation de la cancérogénicité des produits pharmaceutiques |w(CaOODSP)9.603791 |
|---|
| 776 | 0#|tTesting for carcinogenicity of pharmaceuticals |w(CaOODSP)9.615042 |
|---|
| 830 | #0|aGuidance for industry ;|vICH Topic S1B|w(CaOODSP)9.506921 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s58 KB|uhttps://publications.gc.ca/collections/Collection/H42-2-67-14-1999E.pdf|yICH Topic S1B |
|---|